International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
OpenCitations
Works that cite this article, indexed by OpenCitations.
Semi-random mutagenesis profile of BCR-ABL during imatinib resistance acquirement in K562 cells
Molecular Medicine Reports 16(6) (2017)
Yan Dong; Xiaotong Gao; Yingxin Zhao; Mengying Wei; Lingmin Xu; Guodong Yang; Li Liu
Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells
Cancer Biology & Therapy 19(8) (2018)
Ling Cheng; Ying Tang; Xing Chen; Lei Zhao; Songya Liu; Yanna Ma; Na Wang; Kuangguo Zhou; Jianfeng Zhou; Mi Zhou
Cysteine‐rich protein 61 regulates the chemosensitivity of chronic myeloid leukemia to imatinib mesylate through the nuclear factor kappa B/Bcl‐2 pathway
Cancer Science 110(8) (2019)
Yanfang Song; Qing Lin; Zhaolian Cai; Taisen Hao; Yaohan Zhang; Xianjin Zhu
The growth of K562 human leukemia cells was inhibited by therapeutic neural stem cells in cellular and xenograft mouse models
Cytotherapy 20(9) (2018)
GEON-TAE PARK; JAE-RIM HEO; SEUNG U. KIM; KYUNG-CHUL CHOI
Investigation of TSRP reverses imatinib resistance through the PI3K / Akt pathway in chronic myeloid leukemia
Annals of Hematology 103(12) (2024)
Ying He; Jiyuan Ding; Liqin Liu; Jiajun Chen; Hong Zhong; Changyu Li; Xiaofeng Xu
A Chemical Approach to Overcome Tyrosine Kinase Inhibitors Resistance: Learning from Chronic Myeloid Leukemia
Current Medicinal Chemistry 26(33) (2019)
Enrico Zanforlin; Giuseppe Zagotto; Giovanni Ribaudo